Perimenopause symptom scale: Flo, Mayo Clinic tool validated in 1,255-woman study

Representative image: IqbalStock / Pixabay
A 16-item Perimenopause Symptom Scale by Flo Health and Mayo Clinic clinicians was validated in a study of 1,255 US women, announced on 12 November 2026.
What Happened
A 16-question checklist for tracking perimenopause symptoms, called the Perimenopause Symptom Scale (Peri-SS), has been validated in a study published in Menopause, the journal of The Menopause Society, according to an announcement made on Thursday, 12 November 2026. The scale was developed by scientists at the women's health app company Flo Health together with clinicians from Mayo Clinic. The study tested it on 1,255 women aged 35 to 59 in the United States and reported that its scores closely matched those of an older, widely used menopause questionnaire.
Perimenopause Symptom Scale: key facts
- The tool: the Perimenopause Symptom Scale (Peri-SS), a 16-item self-assessment for digital use, co-developed by Flo Health scientists and Mayo Clinic clinicians.
- Publication: the validation study appeared in the journal Menopause; the announcement was made on Thursday, 12 November 2026.
- Who took part: 1,255 women aged 35 to 59 in the United States, recruited through the online research platform Prolific; 633 of them described themselves as perimenopausal.
- How it was tested: participants filled in the Peri-SS, the Menopause Rating Scale (MRS) and a quality-of-life measure called EQ-5D-5L at the start, and again 7 to 14 days later.
- Main result: Peri-SS scores were strongly correlated with MRS scores, with a correlation of 0.88, according to the study.
- Scoring: each symptom is rated for the past 30 days; the total is scaled from 0 to 100 and placed in four severity bands: 0 to 8, 9 to 18, 19 to 35, and 36 and above.
- Limits named in reports of the study: it has been validated only in English and only among women in the United States.
Perimenopause Symptom Scale: why it matters
Perimenopause is the stage before menopause, when hormone levels start to change and periods become irregular. Symptoms such as hot flushes and night sweats (called vasomotor symptoms), poor sleep and mood changes vary widely. Because these symptoms come and go, and because many of them overlap with stress, ageing or a busy working life, women often find it hard to describe them clearly to a doctor, or to tell whether they are getting better or worse.
A validated scale is a questionnaire that researchers have tested to show that it measures what it claims to measure and gives consistent results. The Menopause Rating Scale, used here as the yardstick, has been in use for many years, but it was designed around menopause in general. The Peri-SS is aimed specifically at perimenopause and at use on a phone. The study's authors reported that the new scale also picked up changes in symptoms over time, and that among women who said they were perimenopausal, it was more reliable than the MRS. Reports of the study said the internal consistency of its symptom groups varied, with scores between 0.5 and 0.8 on the standard measure used for this, Cronbach's alpha, where higher is more consistent.
There is a commercial angle to keep in view. The scale was built by Flo Health, which runs a popular period- and cycle-tracking app, and the results were announced through the company's own press release. The findings went through a peer-reviewed journal, but the developer of the tool also promoted them. The study shows only that the scale measures symptoms consistently, not that it improves treatment.
For women in India, the result is a reminder of a wider gap. The scale has been tested only in English and only with women in the United States, so there is no evidence yet on how well it works for women who speak other languages; that would need its own testing.
Peepals calculation: Of the 1,255 women in the study, 633 identified as perimenopausal, which is about 50.4% (633 ÷ 1,255 = 0.504), so roughly half of the sample was in the stage the scale is designed for. A correlation of 0.88 between the Peri-SS and the MRS means that about 77% of the variation in one score lines up with the other (0.88 × 0.88 = 0.774). Our calculation from the reported figures.
Impact
Short-term: Users of symptom-tracking apps may see more tools that score perimenopause symptoms. A score is a record of symptoms, not a diagnosis.
Long-term: If the scale is tested in other languages and countries, it could give researchers a common way to compare perimenopause symptoms across groups of women.
Who is affected: Women in their late 30s to late 50s balancing work and family with irregular cycles, poor sleep or mood changes; gynaecologists and general physicians; and researchers studying midlife women's health.
Key Takeaway
A 16-question perimenopause symptom scale built by Flo Health with Mayo Clinic clinicians matched an established menopause questionnaire closely in a study of 1,255 US women, but it has not yet been tested outside the United States or in languages other than English.
Questions and Answers
What is the Perimenopause Symptom Scale (Peri-SS)?
It is a 16-item questionnaire for rating perimenopause symptoms over the past 30 days, designed for digital use. It was developed by Flo Health scientists with Mayo Clinic clinicians, and its validation study was published in the journal Menopause, as announced on 12 November 2026.
How was the perimenopause scale tested?
1,255 US women aged 35 to 59, recruited online through Prolific, completed the Peri-SS, the Menopause Rating Scale and a quality-of-life questionnaire, then repeated them 7 to 14 days later. The Peri-SS scores correlated with the Menopause Rating Scale at 0.88.
Can women in India use the Peri-SS score to diagnose perimenopause?
No. A symptom score is not a diagnosis, and the scale has so far been validated only in English among women in the United States. Anyone with troubling symptoms should speak to a doctor.
Who developed and announced the perimenopause scale study?
The scale was developed by Flo Health, a women's health app company, with Mayo Clinic clinicians, and the results were announced through Flo Health's press release, so the developer of the tool also promoted the findings.
Disclaimer: Prepared by the Peepals newsroom from publicly available sources with AI assistance. Information is accurate to the best of our knowledge at the time of publication and may change. Images may be representative. Not professional advice. Report an error via our contact page.
By Vikram Joshi, Life Balance CorrespondentCovers Life Balance and more for Peepals Shakti. All stories by Vikram Joshi
DNA test in maintenance cases: child's welfare not enough, Karnataka HC rules
Sharvari Wagh fronts Abu Jani Sandeep Khosla's Disco Inferno at Art Mumbai
Get the day's stories in your inbox
Peepals Weekly: the week decoded, free. One email a week, unsubscribe in one click.
Vikram Joshi is a pen name of the Peepals Global Editorial Team, which researches, fact-checks and publishes every story. The portrait is an illustration.
Responsible for this story: the Peepals Global Editorial Team, led by editor Prashant Sonar. How we report









